Oxford Nanopore Technologies
ONT · Main Market · Health Care · mcap £1,957m · 200.0p
| Date | Type | Announcement | Day |
|---|---|---|---|
| 14 Oct 26 | Director dealing | Share Incentive Plan - Director/PDMR Shareholding
The Company has been notified by Computershare Trustees Limited, the trustee of the SIP (the "SIP Trustee") that on 14 October 2026, it made an award of Partnership Shares (as defined in the SIP) of 70 Ordinary shares of |
−1.1% |
| 12 Oct 26 | Director dealing | Director/PDMR Shareholding | |
| 01 Oct 26 | Routine | Issue of Equity and Total Voting Rights | |
| 16 Sep 26 | Preliminary injunction against MGI Tech GmbH
Unified Patent Court grants preliminary injunction against MGI Tech GmbH relating to CycloneSEQ sequencing platform |
+1.9% | |
| 14 Sep 26 | Director dealing | Share Incentive Plan - Director/PDMR Shareholding
The Company has been notified by Computershare Trustees Limited, the trustee of the SIP (the "SIP Trustee") that on 14 September 2026, it made an award of Partnership Shares (as defined in the SIP) of 96 Ordinary shares |
−1.8% |
| 09 Sep 26 | Participation in upcoming investor conferences
Oxford Nanopore to participate in upcoming investor conferences |
−0.4% | |
| 04 Sep 26 | Director dealing ⚡ Insider buying | Director/PDMR Shareholding | |
| 04 Sep 26 | Holding | Holding(s) in Company | |
| 04 Sep 26 | Holding | Holding(s) in Company | |
| 01 Sep 26 | Routine | Issue of Equity and Total Voting Rights | |
| 25 Aug 26 | Appointment of CDPO
Oxford Nanopore Technologies plc (LSE: ONT), the company delivering a new generation of nanopore-based molecular sensing], today announces the appointment of David Miller as Chief Development and Product Officer (CDPO), |
+9.8% | |
| 20 Aug 26 | Director dealing | LTIP awards; Director/PDMR Notification
The Company announces the following transaction in connection with one of its employee share plans. |
+17.8% |
| 19 Aug 26 | Results | Half-year Results
Interim results for the six months ended 30 June 2026 |
+14.3% |
| 12 Aug 26 | Director dealing | Share Incentive Plan - Director/PDMR Shareholding
The Company has been notified by Computershare Trustees Limited, the trustee of the SIP (the "SIP Trustee") that on 12 August 2026, it made an award of Partnership Shares (as defined in the SIP) of 114 Ordinary shares of |
−2.2% |
| 03 Aug 26 | Routine | Issue of Equity and Total Voting Rights | |
| 14 Jul 26 | Director dealing | Share Incentive Plan - Director/PDMR Shareholding
The Company has been notified by Computershare Trustees Limited, the trustee of the SIP (the "SIP Trustee") that on 14 July 2026, it made an award of Partnership Shares (as defined in the SIP) of 124 Ordinary shares of £ |
+0.5% |
| 13 Jul 26 | Half Year Trading Update and Notice of Results
Half Year Trading Update and Notice of Results |
−3.6% | |
| 01 Jul 26 | Routine | Issue of Equity and Total Voting Rights | |
| 30 Jun 26 | Changes to Director Roles and Responsibilities
In accordance with UK Listing Rule 6.4.6R, the Company announces that, with effect from 1 July 2026, Nick Keher, Chief Financial Officer, will, in addition to retaining his existing responsibilities, assume responsibilit |
+1.5% | |
| 12 Jun 26 | Director dealing | Share Incentive Plan - Director/PDMR Shareholding
The Company has been notified by Computershare Trustees Limited, the trustee of the SIP (the "SIP Trustee") that on 12 June 2026, it made an award of Partnership Shares (as defined in the SIP) of 121 Ordinary Shares of £ |
−4.3% |
| 04 Jun 26 | Routine | Result of AGM | |
| 01 Jun 26 | Routine | Issue of Equity and Total Voting Rights | |
| 21 May 26 | London Calling Technology Update
Annual customer conference highlights customer-led execution and continued platform innovation |
+4.5% | |
| 21 May 26 | Oxford Nanopore strengthens executive team
Appointment of first Chief Medical Officer and Chief Information Officer |
+4.5% | |
| 13 May 26 | Director dealing | Share Incentive Plan - Director/PDMR Shareholding
The Company has been notified by Computershare Trustees Limited, the trustee of the SIP (the "SIP Trustee") that on 13 May 2026, it made an award of Partnership Shares (as defined in the SIP) of 133 ordinary shares of £0 |
+2.2% |
| 12 May 26 | Director dealing ⚡ Insider buying | Director/PDMR Shareholding | |
| 01 May 26 | Routine | Issue of Equity and Total Voting Rights | |
| 01 May 26 | Routine | Publication of Annual Report and Notice of AGM | |
| 15 Apr 26 | Director dealing | Director/PDMR Shareholding - LTIP and DBP awards | |
| 14 Apr 26 | Director dealing | Share Incentive Plan - Director/PDMR Shareholding
The Company has been notified by Computershare Trustees Limited, the trustee of the SIP (the "SIP Trustee") that on 14 April 2026, it made an award of Partnership Shares (as defined in the SIP) of 136 ordinary shares of |
+7.1% |
| 13 Apr 26 | Director dealing | Director/PDMR Shareholding - LTIP and DBP awards | |
| 02 Apr 26 | Director dealing | Director/PDMR Shareholding | |
| 01 Apr 26 | Routine | Issue of Equity and Total Voting Rights | |
| 26 Mar 26 | Block Admission Application
The Company confirms that a new block admission application (the "New Block Admission Application") has been made to the London Stock Exchange for 50,000,000 ordinary shares of £0.0001 each in the capital of the Company |
−3.0% | |
| 12 Mar 26 | Director dealing | Share Incentive Plan - Director/PDMR Shareholding
The Company has been notified by Computershare Trustees Limited, the trustee of the SIP (the "SIP Trustee") that on 12 March 2026, it made an award of Partnership Shares (as defined in the SIP) of 121 ordinary shares of |
−2.2% |
| 09 Mar 26 | Director dealing | Issue of Equity; Director/PDMR Shareholding | |
| 04 Mar 26 | Upcoming Investor Events and Conferences
Oxford Nanopore to participate in upcoming investor conferences |
+10.2% | |
| 03 Mar 26 | Director dealing | Grant of LTIP awards; Director/PDMR Notification | |
| 03 Mar 26 | Director dealing | Director/PDMR Shareholding | |
| 02 Mar 26 | Routine | Issue of Equity and Total Voting Rights | |
| 02 Mar 26 | Results | Final Results
Annual results for the year ended 31 December 2025 |
−13.8% |
| 27 Feb 26 | Update on legal action against MGI Australia
Update on legal action against MGI Australia Pty Ltd., in the Federal Court of Australia |
−1.0% | |
| 27 Feb 26 | Director Declaration - John O'Higgins
Pursuant to Listing Rule 6.4.9 R(2), Oxford Nanopore Technologies plc (the "Company") confirms that John O'Higgins, Non-Executive Director of the Company, has been nominated for appointment to the Board of Technip Energi |
−1.0% | |
| 12 Feb 26 | Director dealing | Share Incentive Plan - Director/PDMR Shareholding
The Company has been notified by Computershare Trustees Limited, the trustee of the SIP (the "SIP Trustee") that on 12 February 2026, it made an award of Partnership Shares (as defined in the SIP) of 105 ordinary shares |
−1.5% |
| 02 Feb 26 | Routine | Issue of Equity and Total Voting Rights | |
| 14 Jan 26 | Director dealing | Share Incentive Plan - Director/PDMR Shareholding
The Company has been notified by Computershare Trustees Limited, the trustee of the SIP (the "SIP Trustee") that on 14 January 2026, it made an award of Partnership Shares (as defined in the SIP) of 100 ordinary shares o |
+0.4% |
| 12 Jan 26 | Full Year Trading Update and Notice of Results
Full Year Trading Update and Notice of Results |
+9.4% | |
| 07 Jan 26 | Upcoming Investor Events and Conferences
Oxford Nanopore to participate in upcoming investor conferences |
+2.6% | |
| 02 Jan 26 | Routine | Issue of Equity and Total Voting Rights | |
| 12 Dec 25 | Director dealing | Share Incentive Plan - Director/PDMR Shareholding
The Company has been notified by Computershare Trustees Limited, the trustee of the SIP (the "SIP Trustee") that on 12 December 2025, it made an award of Partnership Shares (as defined in the SIP) of 118 ordinary shares |
−4.5% |
| 08 Dec 25 | AGM Post-Meeting Shareholder Engagement Update
In accordance with Provision 4 of the UK Corporate Governance Code, Oxford Nanopore Technologies plc (LSE: ONT) is providing an update to the statements made on 4 June 2025 in relation to the voting outcome of Resolution |
+4.7% | |
| 08 Dec 25 | Board change | Appointment of Francis Van Parys as CEO
Appointment of Francis Van Parys as Chief Executive Officer |
+4.7% |
| 01 Dec 25 | Routine | Issue of Equity and Total Voting Rights | |
| 27 Nov 25 | Upcoming investor conferences
Oxford Nanopore to participate in upcoming investor conferences |
+1.5% | |
| 12 Nov 25 | Director dealing | Share Incentive Plan - Director/PDMR Shareholding
The Company has been notified by Computershare Trustees Limited, the trustee of the SIP (the "SIP Trustee") that on 12 November 2025, it made an award of Partnership Shares (as defined in the SIP) of 104 ordinary shares |
−2.9% |
| 07 Nov 25 | ONT postpones investor event; reaffirms guidance
Oxford Nanopore postpones virtual investor event; reaffirms guidance |
+4.7% | |
| 03 Nov 25 | Routine | Issue of Equity and Total Voting Rights | |
| 16 Oct 25 | Upcoming Investor Conferences and Events
Oxford Nanopore to host an investor event and participate in upcoming investor conferences in November |
+2.5% | |
| 14 Oct 25 | Director dealing | Share Incentive Plan - Director/PDMR Shareholding
The Company has been notified by Computershare Trustees Limited, the trustee of the SIP (the "SIP Trustee") that on 14 October 2025, it made an award of Partnership Shares (as defined in the SIP) of 100 ordinary shares o |
−2.7% |
| 06 Oct 25 | Routine | Block listing Interim Review | |
| 01 Oct 25 | Routine | Issue of Equity and Total Voting Rights | |
| 12 Sep 25 | Director dealing | Share Incentive Plan - Director/PDMR Shareholding
The Company has been notified by Computershare Trustees Limited, the trustee of the SIP (the "SIP Trustee") that on 12 September 2025, it made an award of Partnership Shares (as defined in the SIP) of 89 ordinary shares |
−3.5% |
| 02 Sep 25 | Results | Half-year Results
Interim results for the six months ended 30 June 2025 |
−12.8% |
| 01 Sep 25 | Routine | Issue of Equity and Total Voting Rights | |
| 13 Aug 25 | Director dealing | Share Incentive Plan - Director/PDMR Notification
The Company has been notified by Computershare Trustees Limited, the trustee of the SIP (the "SIP Trustee") that on 13 August 2025, it made an award of Partnership Shares (as defined in the SIP) of 73 ordinary shares of |
+3.5% |
| 11 Aug 25 | Board change | Chief Executive Officer Succession
Oxford Nanopore Technologies plc (LSE: ONT), the company delivering a new generation of molecular sensing technology based on nanopores, today announces that Gordon Sanghera has notified the Board of his intention to ste |
−2.7% |
| 08 Aug 25 | Result of Audit Tender
Oxford Nanopore Technologies (LSE: ONT) ("Oxford Nanopore" or the "Group") the company behind a new generation of molecular sensing technology based on nanopores, today announces that, following the conclusion of a forma |
+1.2% | |
| 06 Aug 25 | Commencement of legal action against MGI Australia
Oxford Nanopore announces commencement of legal action against MGI Australia Pty Ltd., in the Federal Court of Australia |
−1.4% | |
| 01 Aug 25 | Routine | Issue of Equity and Total Voting Rights | |
| 29 Jul 25 | Holding | Holding(s) in Company | |
| 21 Jul 25 | Half Year Trading Update and Notice of Results
Half Year Trading Update and Notice of Results |
+19.2% | |
| 14 Jul 25 | Director dealing | Share Incentive Plan - Director/PDMR Notification
The Company has been notified by Computershare Trustees Limited, the trustee of the SIP (the "SIP Trustee") that on 14 July 2025, it made an award of Partnership Shares (as defined in the SIP) of 101 ordinary shares of £ |
+2.4% |
| 04 Jul 25 | Publication of 2024 Sustainability Report
Oxford Nanopore Technologies plc (LSE: ONT), the company behind a new generation of molecular sensing technology based on nanopores, is pleased to announce that its 2024 Sustainability Report has been published on the Co |
+0.1% | |
| 01 Jul 25 | Routine | Issue of Equity and Total Voting Rights | |
| 27 Jun 25 | Holding | Holding(s) in Company | |
| 18 Jun 25 | Holding | Holding(s) in Company | |
| 12 Jun 25 | Director dealing | Share Incentive Plan - Director/PDMR Notification
The Company has been notified by Computershare Trustees Limited, the trustee of the SIP (the "SIP Trustee") that on 12 June 2025, it made an award of Partnership Shares (as defined in the SIP) of 119 ordinary shares of £ |
−2.2% |
| 11 Jun 25 | Holding | Holding(s) in Company | |
| 05 Jun 25 | Changes in Composition of Remuneration Committee
The Company is pleased to announce that Heather Preston has been appointed as Chair of the Remuneration Committee with immediate effect. |
+0.3% | |
| 04 Jun 25 | Routine | Result of AGM | |
| 03 Jun 25 | Routine | Issue of Equity and Total Voting Rights | |
| 02 Jun 25 | Holding | Holding(s) in Company | |
| 22 May 25 | London Calling Technology Update
Annual customer conference highlights how Oxford Nanopore's unique molecular sensing platform empowers real-time insights, consistent results, and multiomic discovery |
+0.5% | |
| 14 May 25 | Director dealing | Share Incentive Plan - Director/PDMR Notification
The Company has been notified by COMPUTERSHARE TRUSTEES LIMITED, the trustee of the SIP (the "SIP Trustee") that on 14 May 2025, it made an award of Partnership Shares (as defined in the SIP) of 112 ordinary shares of £0 |
−2.6% |
| 01 May 25 | Routine | Issue of Equity and Total Voting Rights | |
| 30 Apr 25 | Director dealing | Founder LTIP - Director/PDMR Notification
In June 2021, the Company granted a one-off legacy conditional performance-related award under the Oxford Nanopore Technologies Limited Long-Term Incentive Plan 2021 approved by shareholders prior to the Company's initia |
−0.1% |
| 30 Apr 25 | Routine | Publication of Annual Report and Notice of AGM | |
| 24 Apr 25 | Holding | Holding(s) in Company | |
| 14 Apr 25 | Director dealing | Director/PDMR Shareholding - LTIP and DBP awards | |
| 14 Apr 25 | Director dealing | Share Incentive Plan - Director/PDMR Notification
The Company has been notified by Computershare Trustees Limited, the trustee of the SIP (the "SIP Trustee") that on 14 April 2025, it made an award of Partnership Shares (as defined in the SIP) of 129 ordinary shares of |
+7.9% |
| 10 Apr 25 | Holding | Holding(s) in Company | |
| 09 Apr 25 | Routine | Block listing Interim Review | |
| 09 Apr 25 | Oxford Nanopore and Cepheid collaboration
Oxford Nanopore and Cepheid partner to advance automated sequencing-based solutions |
−2.1% | |
| 02 Apr 25 | Routine | Issue of Equity and Total Voting Rights | |
| 26 Mar 25 | Director dealing | Director/PDMR Shareholding | |
| 14 Mar 25 | Director dealing | SIP PDMR Notification - Correction
The following amendment has been made to the 'PDMR Notification' announcement released on 13 March 2025 at 15:00 under RNS No: 5980A. |
−1.6% |
| 13 Mar 25 | Director dealing | Share Incentive Plan - Director/PDMR Notification
Share Incentive Plan ("SIP") PDMR Notification and correction to previous PDMR Notification |
+1.5% |
| 12 Mar 25 | Director dealing | Director/PDMR Shareholding | |
| 06 Mar 25 | Holding | Holding(s) in Company | |
| 05 Mar 25 | Holding | Holding(s) in Company | |
| 04 Mar 25 | Results | Final Results
Annual results for the year ended 31 December 2024 |
−13.1% |
| 03 Mar 25 | Routine | Issue of Equity and Total Voting Rights | |
| 19 Feb 25 | Holding | Holding(s) in Company | |
| 07 Feb 25 | Director dealing | Share Incentive Plan - Director/PDMR Notification
The Company has been notified by Solium Trustee (UK) Limited, the trustee of the SIP (the "SIP Trustee") that on 07 February 2025, it made an award of Partnership Shares (as defined in the SIP) of 109 ordinary shares of |
−1.5% |
| 04 Feb 25 | Holding | Holding(s) in Company | |
| 03 Feb 25 | Routine | Issue of Equity and Total Voting Rights | |
| 13 Jan 25 | Director dealing | SIP PDMR Notification and Correction
Share Incentive Plan ("SIP") PDMR Notification and correction to previous PDMR Notification |
+8.9% |
| 13 Jan 25 | Full Year Trading Update and Notice of Results
Full Year Trading Update and Notice of Results |
+8.9% | |
| 07 Jan 25 | Presentation at 43rd Annual J.P. Morgan Conference
Oxford Nanopore to Present at 43rd Annual J.P. |
+1.4% | |
| 06 Jan 25 | Holding | Holding(s) in Company | |
| 02 Jan 25 | Routine | Issue of Equity and Total Voting Rights | |
| 16 Dec 24 | Board change | Directorate Change - Appointment of SID
The Company is pleased to announce that Kate Priestman has been appointed as Senior Independent Director with immediate effect. |
+1.4% |
| 11 Dec 24 | Director dealing | Share Incentive Plan - Director/PDMR Shareholding
The Company has been notified by Solium Trustee (UK) Limited, the trustee of the SIP (the "SIP Trustee") that on 11 December 2024, it made an award of Partnership Shares (as defined in the SIP) of 106 ordinary shares of |
+4.6% |
| 02 Dec 24 | Routine | Issue of Equity and Total Voting Rights | |
| 28 Nov 24 | Director dealing | Class A LAT share - Director/PDMR Notification
Gift of class A limited anti-takeover share - Director/PDMR Notification |
+3.4% |
| 27 Nov 24 | Oxford Nanopore and UK Biobank collaboration
Oxford Nanopore and UK Biobank to create world's largest epigenetic dataset targeting the causes of cancer, dementia, complex disease |
+4.5% | |
| 26 Nov 24 | Proposed cancellation of LAT shares
The Company today announces the proposed cancellation of its three limited anti-takeover shares ("LAT shares"), being one class A LAT share of £1.00, one class B LAT share of £1.00 and one class C LAT share of £1.00. |
+0.3% | |
| 21 Nov 24 | Holding | Holding(s) in Company | |
| 12 Nov 24 | Director dealing | Share Incentive Plan - Director/PDMR Shareholding
The Company has been notified by Solium Trustee (UK) Limited, the trustee of the SIP (the "SIP Trustee") that on 12 November 2024, it made an award of Partnership Shares (as defined in the SIP) of 105 ordinary shares of |
−0.4% |
| 11 Nov 24 | Changes to the senior leadership team
Oxford Nanopore announces changes to the senior leadership team |
+3.1% | |
| 06 Nov 24 | Approval of the transfer of listing category
Further to the announcement on 8 October 2024, Oxford Nanopore Technologies plc is pleased to announce the approval by the Financial Conduct Authority (the "FCA") of the transfer of listing category of its ordinary share |
−7.1% | |
| 04 Nov 24 | Holding | Holding(s) in Company | |
| 01 Nov 24 | Issue of Capital and Total Voting Rights
The Company today announces in respect of the period from 15 October to 31 October 2024, the issue of 88,454 ordinary shares of £0.0001 each ("Ordinary Shares"), following the exercise of options granted under the Compan |
+0.2% | |
| 16 Oct 24 | Director dealing | Founder LTIP - Director/PDMR Notification
In June 2021, the Company granted a one-off legacy conditional performance-related award under the Oxford Nanopore Technologies Limited Long-Term Incentive Plan 2021 approved by shareholders prior to the Company's initia |
+3.2% |
| 15 Oct 24 | Holding | Holding(s) in Company | |
| 15 Oct 24 | Routine | Issue of Equity and Total Voting Rights | |
| 14 Oct 24 | Routine | Admission to Trading on the London Stock Exchange | |
| 11 Oct 24 | Director dealing | Share Incentive Plan - Director/PDMR Shareholding
The Company has been notified by Solium Trustee (UK) Limited, the trustee of the SIP (the "SIP Trustee") that on 11 October 2024, it made an award of Partnership Shares (as defined in the SIP) of 99 ordinary shares of £0 |
+1.4% |
| 10 Oct 24 | New issue in connection with LTIP awards
Oxford Nanopore Technologies plc ("Oxford Nanopore" or "the Company") |
−4.7% | |
| 08 Oct 24 | Notice of intention to transfer listing category
Oxford Nanopore Technologies plc ("Oxford Nanopore" or the "Company"), the company delivering a new generation of nanopore-based molecular sensing technology, today announces that it is proposing to transfer the listing |
+2.2% | |
| 07 Oct 24 | Routine | Block Listing Interim Review | |
| 02 Oct 24 | Routine | Issue of Equity and Total Voting Rights | |
| 01 Oct 24 | Board change | Daniel Mahony appointed as Non-Executive Director
Oxford Nanopore Technologies plc (LSE: ONT) (''Oxford Nanopore'' or ''the Group''), the company delivering a new generation of nanopore-based molecular sensing technology, is pleased to announce that Dr Daniel Mahony wil |
+0.0% |
| 13 Sep 24 | Director dealing | Share Incentive Plan - Director/PDMR Shareholding
The Company has been notified by Solium Trustee (UK) Limited, the trustee of the SIP (the "SIP Trustee") that on 12 September 2024, it made an award of Partnership Shares (as defined in the SIP) of 102 ordinary shares of |
+5.4% |
| 10 Sep 24 | Seeks discovery into expected breach of contract
Oxford Nanopore seeks discovery in connection with anticipated breach of contract action |
−2.2% | |
| 05 Sep 24 | Oxford Nanopore to present at upcoming conferences
Oxford Nanopore to present at upcoming investor conferences |
+0.4% | |
| 03 Sep 24 | Holding | Holding(s) in Company | |
| 03 Sep 24 | Routine | Issue of Equity and Total Voting Rights | |
| 03 Sep 24 | Results | Half-year Results
Interim results for the six months ended 30 June 2024 |
+5.4% |
| 30 Aug 24 | Notice of Interim Results Presentation
Oxford Nanopore Technologies plc (LSE: ONT) ("Oxford Nanopore" or the "Group"), the company behind a new generation of molecular sensing technology based on nanopores, will announce its interim results for the six months |
−1.0% | |
| 20 Aug 24 | Holding | Holding(s) in Company | |
| 15 Aug 24 | Holding | Holding(s) in Company | |
| 14 Aug 24 | Holding | Holding(s) in Company | |
| 13 Aug 24 | Director dealing | Share Incentive Plan - Director/PDMR Shareholding
The Company has been notified by Solium Trustee (UK) Limited, the trustee of the SIP (the "SIP Trustee") that on 13 August 2024, it made an award of Partnership Shares (as defined in the SIP) of 122 ordinary shares of £0 |
+1.3% |
| 09 Aug 24 | Holding | Holding(s) in Company | |
| 09 Aug 24 | Director Declaration
Pursuant to Listing Rule 6.4.9 R(2), Oxford Nanopore Technologies plc (the "Company") confirms that Heather Preston, Non-Executive Director of the Company, was appointed to the Board of Aligos Therapeutics (Nasdaq: ALGS) |
−0.7% | |
| 07 Aug 24 | Holding | Holding(s) in Company | |
| 05 Aug 24 | Admission of Ordinary Shares & Total Voting Rights
Admission of Ordinary Shares and Total Voting Rights |
−2.7% | |
| 05 Aug 24 | Singapore Precision Medicine prog
Oxford Nanopore to sequence 10,000 genomes for Singapore's National Precision Medicine (NPM) programme |
−2.7% | |
| 01 Aug 24 | Routine | Issue of Equity and Total Voting Rights | |
| 01 Aug 24 | Investment from Novo Holdings and Equity Issue
Oxford Nanopore attracts investment from Novo Holdings and completes Equity Issue of £80 million |
+7.6% | |
| 31 Jul 24 | Fundraise | Investment from Novo Holdings and proposed placing
Oxford Nanopore attracts investment from Novo Holdings and announces proposed placing of new ordinary shares |
+1.8% |
| 24 Jul 24 | Trading update | Half Year Trading Update
· Trading in-line with both revenue and gross margin guidance in the face of challenging end-markets |
+10.1% |
| 23 Jul 24 | Plasmidsaurus collaboration and contract expansion
Oxford Nanopore and Plasmidsaurus announce collaboration and multi-year, multi-million dollar contract expansion |
−0.2% | |
| 16 Jul 24 | Appointment of corporate broker
Oxford Nanopore Technologies plc (LSE: ONT) ("Oxford Nanopore"), the company delivering a new generation of nanopore-based molecular sensing technology, today announces the appointment of Berenberg as joint corporate bro |
−0.5% | |
| 11 Jul 24 | Director dealing | Share Incentive Plan - Director/PDMR Shareholding
The Company has been notified by Solium Trustee (UK) Limited, the trustee of the SIP (the "SIP Trustee") that on 11 July 2024, it made an award of Partnership Shares (as defined in the SIP) of 146 ordinary shares of £0.0 |
+1.1% |
| 03 Jul 24 | Director dealing | Founder LTIP - Director/PDMR Notification
On 2 July 2024, Gordon Sanghera, a Director and a Person Discharging Managerial Responsibilities, sold 45,466 ordinary shares of £0.0001 each to meet a portion of his tax liabilities in respect of the release of his awar |
+3.1% |
| 01 Jul 24 | Routine | Total Voting Rights | |
| 28 Jun 24 | Director dealing | Founder LTIP - Director/PDMR Notification
In June 2021, the Company granted a one-off legacy conditional performance-related award under the Oxford Nanopore Technologies Limited Long-Term Incentive Plan 2021 approved by shareholders prior to the Company's initia |
−3.7% |
| 21 Jun 24 | Routine | Issue of Equity and Total Voting Rights | |
| 21 Jun 24 | Routine | Admission to Trading on the London Stock Exchange | |
| 19 Jun 24 | Routine | Issue of Equity | |
| 11 Jun 24 | Director dealing | Share Incentive Plan - Director/PDMR Shareholding
The Company has been notified by Solium Trustee (UK) Limited, the trustee of the SIP (the "SIP Trustee") that on 11 June 2024, it made an award of Partnership Shares (as defined in the SIP) of 147 ordinary shares of £0.0 |
+1.3% |
| 10 Jun 24 | Routine | Result of AGM; Director Responsibilities | |
| 07 Jun 24 | Director dealing | PDMR/PCA Notification | |
| 03 Jun 24 | Routine | Issue of Equity and Total Voting Rights | |
| 23 May 24 | London Calling Technology Update
Announcements highlighted breakthrough technology performance and updates to Oxford Nanopore's IVD pipeline at annual customer conference |
+2.1% | |
| 13 May 24 | Director dealing | Share Incentive Plan - Director/PDMR Shareholding
The Company has been notified by Solium Trustee (UK) Limited, the trustee of the SIP (the "SIP Trustee") that on 13 May 2024, it made an award of Partnership Shares (as defined in the SIP) of 131 ordinary shares of £0.00 |
−3.6% |
| 01 May 24 | Routine | Issue of Equity and Total Voting Rights | |
| 01 May 24 | Director dealing | Director/PDMR Shareholding | |
| 30 Apr 24 | Routine | Publication of Annual Report and Notice of AGM | |
| 12 Apr 24 | Study unlocks insights into disease and longevity
New nanopore-based research unlocks insights into disease and longevity |
−1.7% | |
| 12 Apr 24 | Director dealing | LTIP and DBP; Director/PDMR Notification
Grant of LTIP and DBP awards and vesting of DBP awards; Director/PDMR Notification |
−1.7% |
| 11 Apr 24 | Director dealing | Share Incentive Plan - Director/PDMR Shareholding
The Company has been notified by Solium Trustee (UK) Limited, the trustee of the SIP (the "SIP Trustee") that on 11 April 2024, it made an award of Partnership Shares (as defined in the SIP) of 130 ordinary shares of £0. |
−2.9% |
| 08 Apr 24 | Routine | Block Listing Interim Review | |
| 02 Apr 24 | Routine | Issue of Equity and Total Voting Rights | |
| 28 Mar 24 | Holding | Holding(s) in Company | |
| 12 Mar 24 | Director dealing | Share Incentive Plan - Director/PDMR Shareholding
The Company has been notified by Solium Trustee (UK) Limited, the trustee of the SIP (the "SIP Trustee") that on 12 March 2024, it made an award of Partnership Shares (as defined in the SIP) of 102 ordinary shares of £0. |
−4.2% |
| 12 Mar 24 | Oxford Nanopore to Present at Barclays Conference
Oxford Nanopore to Present at the Barclays 26th Annual Global Healthcare Conference |
−4.2% | |
| 08 Mar 24 | Director dealing | Director/PDMR Shareholding | |
| 07 Mar 24 | Director dealing | Director/PDMR Shareholding | |
| 06 Mar 24 | Results | FY23 Preliminary Results
Preliminary results for the year ended 31 December 2023 |
+2.7% |
| 01 Mar 24 | Routine | Issue of Equity and Total Voting Rights |
Company filings. Not investment advice.